The Respiratory Effectiveness Group (REG; www.effectivenessevaluation.org) supported the Expert Adherence Panel Meeting at which many of the concepts presented in this paper were first discussed. REG also supported the manuscript submission costs. ALD, EvG, and MdB have received funding from the European Community's 7th Framework (FP7/2007-2013) under grant agreement no. 282593. Teva supported the meeting costs at which the concepts in this paper were discussed by the co-authors and the open access publication fee for this article. The authors had full editorial control over the ideas presented.Peer reviewedPublisher PD
Adherence to medication comprises a multiphased temporal process involving (1) initiation of prescri...
Individuals with a chronic lung disease, such as COPD, are dependent on the use of inhaled medicatio...
The circumstances and drivers of the decision to initiate, implement, or persist with a medication d...
Adequate medication adherence is key for optimal benefit of pharmacological treatments. A wealth of ...
Part of this work, conducted by E. Van Ganse, has been performed in the context of the ASTRO-LAB pro...
Adherence to medication comprises a multiphased temporal process involving (1) initiation of prescri...
Adequate medication adherence is key for optimal benefit of pharmacological treatments. A wealth of ...
Recognition of Commercial Support: The Expert Adherence Panel Meeting from which the concepts presen...
Inhaled therapies are the backbone of asthma and chronic obstructive pulmonary disease management, h...
Medication non-adherence, defined as any deviation from the regimen recommended by their healthcare ...
Adherence to medication comprises a multiphased temporal process involving (1) initiation of prescri...
BACKGROUND: Medication non-adherence management of patients with asthma/COPD remains challenging. Gi...
Adherence to medication comprises a multiphased temporal process involving (1) initiation of prescri...
Individuals with a chronic lung disease, such as COPD, are dependent on the use of inhaled medicatio...
The circumstances and drivers of the decision to initiate, implement, or persist with a medication d...
Adequate medication adherence is key for optimal benefit of pharmacological treatments. A wealth of ...
Part of this work, conducted by E. Van Ganse, has been performed in the context of the ASTRO-LAB pro...
Adherence to medication comprises a multiphased temporal process involving (1) initiation of prescri...
Adequate medication adherence is key for optimal benefit of pharmacological treatments. A wealth of ...
Recognition of Commercial Support: The Expert Adherence Panel Meeting from which the concepts presen...
Inhaled therapies are the backbone of asthma and chronic obstructive pulmonary disease management, h...
Medication non-adherence, defined as any deviation from the regimen recommended by their healthcare ...
Adherence to medication comprises a multiphased temporal process involving (1) initiation of prescri...
BACKGROUND: Medication non-adherence management of patients with asthma/COPD remains challenging. Gi...
Adherence to medication comprises a multiphased temporal process involving (1) initiation of prescri...
Individuals with a chronic lung disease, such as COPD, are dependent on the use of inhaled medicatio...
The circumstances and drivers of the decision to initiate, implement, or persist with a medication d...